S,NCTId,eudraCT,study_completion_year,title,acronym,has_results_or_publications_within_1y,has_results_or_publications_within_3y
ðŸŸ§,NCT01360242,,2013,Patients Presenting With Acute STEMI Treated With Primary PCI : Comparison of the Impact of the MIMI Approach With a Conventional Strategy of Immediate Stenting,MIMI,False,True
ðŸŸ¥,NCT02735005,,2017,"Epidemiology of Aging of People With Disabilities - Gerontological Sector ""Rumilly-Annecy-Saint-Julien-Pays de Gex-Bellegarde"" : Description of the Population in an Attempt to Identify Ways to Implement to Meet the Needs in Aging",PHV,False,False
ðŸŸ¥,NCT04089397,,2020,Randomized Open-label Trial Evaluating Light Therapy on Sleep Quality in Dialysis Patients,LUMIDIAL,False,False
ðŸŸ¥,NCT03493750,,2021,"Oral Evaluation by the Nurses From the Office of Access to Healthcare (""PASS"") for Vulnerable People as a Vector for the Detection of Oral Diseases to Improve Access to the Appropriate Healthcare Branch - PASSDENT Study",PASSDENT,False,False
ðŸŸ§,NCT05154383,2021-004573-32,2022,"Effect of High-Dose Quadrivalent Influenza Vaccine (EflueldaÂ®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression",INFLUOMICS,False,True
ðŸŸ¥,,2018-001105-85,2023,"A multicenter phase II study evaluating denosumab (XGEVAÂ®) in combination with nivolumab (OPDIVOÂ®) as second-line therapy for patients with stage IV non-smallâ€“cell lung cancer (squamous and non-squamous) with bone metastases 
 
 
 Etude de phase II multicentrique de lâ€™Ã©valuation du denosumab (XGEVAÂ®) associÃ© au nivolumab (OPDIVOÂ®) en 2Ã¨me ligne de traitement chez des patients prÃ©sentant un cancer bronchique non Ã  petites cellules (Ã©pidermoÃ¯de et non Ã©pidermoÃ¯de) de stade IV, porteurs de mÃ©tastases osseuses","DENIVOS 
 
 
 DENIVOS",False,False
